507487-89-0Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1DYTKVFHLKPDNRW-UHFFFAOYSA-NUsesCDK2/9 Inhibitor has been characterized in complex with a variety of inhibitors, but the majority of structures solved are in the inactive form. Research suggests that monomeric CDK2 conformation can be selectively inhibited.
Loading…
507487-89-0DTXSID30332265CHEMBL298445